Lucid Diagnostics (LUCD) Accumulated Expenses (2020 - 2026)

Lucid Diagnostics' Accumulated Expenses history runs 7 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• Quarterly Accumulated Expenses rose 6.13% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 6.13% YoY) and the FY2025 annual result came in at $2.7 million, down 3.89% from the prior year.
• Accumulated Expenses was $2.2 million for Q1 2026 at Lucid Diagnostics, down from $2.7 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $3.8 million in Q4 2023 and bottomed at $1.1 million in Q3 2022.
• A 5-year average of $2.4 million and a median of $2.3 million in 2025 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses surged 266.79% — and 2024, when it sank 39.69%.
• Lucid Diagnostics' Accumulated Expenses stood at $1.4 million in 2022, then soared by 165.45% to $3.8 million in 2023, then decreased by 26.35% to $2.8 million in 2024, then fell by 3.89% to $2.7 million in 2025, then slipped by 19.09% to $2.2 million in 2026.
• Business Quant data shows LUCD's Accumulated Expenses at $2.2 million in Q1 2026, $2.7 million in Q4 2025, and $2.3 million in Q3 2025.